Summit Therapeutics Inc
SMMT
Market Cap$3.17B
Close$
$-0.07
101.6% downside
Current Fair Value
101.6% downsideOvervalued by 101.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.17 Billion |
|---|---|
| Enterprise Value | $3.06 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.45 |
| Beta | 1.58 |
| Outstanding Shares | 701,979,596 |
| Avg 30 Day Volume | 2,066,323 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -5.3 |
|---|---|
| PEG | 43.25 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 13900.79 |
| Enterprise Value to EBIT | -5.26 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.9 |
Revenue Sources
No data
ESG Score
No data